English Polski
Vol 16, No 2 (2021)
Case report
Published online: 2021-04-30

open access

Page views 1028
Article views/downloads 496
Get Citation

Connect on Social Media

Connect on Social Media

Severe chronic thromboembolic pulmonary hypertension in a patient after splenectomy for hereditary spherocytosis: the need for long-term surveillance and closer cooperation between haematologists and cardiologists

Maja Klimkiewicz1, Grzegorz Sławiński1, Anna Faran1, Alicja Dąbrowska-Kugacka1, Grzegorz Romanowicz2, Marcin Kurzyna3, Ewa Lewicka1
Folia Cardiol 2021;16(2):130-133.

Abstract

We present the case of a 34-year-old female patient with severe pulmonary hypertension diagnosed > 15 years after splenectomy to emphasize the need to monitor patients after splenectomy for the development of chronic thromboembolic pulmonary hypertension (CTEPH). The lack of screening tests for this group of patients, as in the described case, resulted in a serious clinical condition of the patient at the time of diagnosis. Without specialized treatment, the probability of her survival at 5 years was only 10%. Close collaboration between haematologists and cardiologists is mandatory in the management of post-splenectomy patients Life-long surveillance is needed in these patients due to the risk of CTEPH. The development of a screening program for post-splenectomy patients is required.

Article available in PDF format

View PDF Download PDF file

References

  1. Jaïs X, Ioos V, Jardim C, et al. Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax. 2005; 60(12): 1031–1034.
  2. Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011; 124(18): 1973–1981.
  3. Galiè N, Humbert M, Vachiery JL, et al. ESC Scientific Document Group . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016; 37(1): 67–119.
  4. Riedel M, Stanek V, Widimsky J, et al. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest. 1982; 81(2): 151–158.
  5. Delcroix M, Lang I, Pepke-Zaba J, et al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an International Prospective Registry. Circulation. 2016; 133(9): 859–871.